Latest News
Featured News
Interim Results and Business Update
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell announces Genmab exercises option to a second commercial license agreement
Modi-2 a vaccine stimulating CD4 responses to homocitrullinated self epitopes as therapy for solid cancers
Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced Melanoma
Interim Report 31st October 2024
Result of 2024 Annual General Meeting
AGM Presentation 2024
Notice of Annual General Meeting October 2024
Scancell announces strengthening of leadership team as it closes on value-generating inflection points
Notice of AGM
Scancell Preliminary Results for the Year Ended 30 April 2024
Scancell signs strategic partnership with PharmaJet for use of the Stratis® IM Needle-free delivery System in the development of SCIB1/iSCIB1+ cancer vaccine for Advanced Melanoma
Annual Meeting of the American Society of Clinical Oncology (ASCO), 31 May – 4 June 2024, Chicago, Illinois, USA
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.